Vestibular modulation of plasma vasopressin levels in rats.
Recent studies, which have shown an increase of plasma vasopressin (VP) in experimental motion sickness and the efficacy of VP antagonists for motion sickness, suggest an important role of VP in the development of vestibulo-autonomic responses. We have recently found evidence of the co-existence of vasopressinergic neurons with the stress-sensitive chemokinergic neuronal system in the hypothalamo-pituitary pathway in rats, which uses cytokine-induced neutrophil chemoattractant (CINC) as an effector molecule. In this study, to elucidate possible roles of VP and CINC in the vestibulo-autonomic responses, we simultaneously measured plasma VP and CINC concentrations after electrical or caloric vestibular stimulation in urethane-anesthetized rats. Electrical vestibular stimulation with more than 200 microA increased the plasma levels of VP in a current intensity-dependent manner, and stimulation with 500 microA increased the plasma VP levels to 350% of the normal control group, which received no stimulation. Caloric vestibular stimulation with cold water increased the plasma VP levels to 262% of the control group, which received caloric stimulation with water at 37 degrees C, and stimulation with warm water tended to increase the plasma VP levels. Plasma CINC levels were neither affected by electrical nor caloric vestibular stimulation. These findings indicate that vestibular stimulation increased plasma levels of VP but not CINC, and this vestibular-induced activation of VP neurons may be involved in a mechanism of vestibulo-autonomic responses.
Horii
A
A
Department of Otolaryngology and Sensory Organ Surgery, Osaka University Medical School, 2-2 Yamadaoka, Suita, 565-0871, Osaka, Japan. ahorii@ent.med.osaka-u.ac.jp
Koike
K
K
Uno
A
A
Uno
Y
Y
Kubo
T
T
D000818:Animals; D001341:Autonomic Nervous System / Q000378:metabolism*; D002150:Caloric Tests; D019743:Chemokines, CXC; D002630:Chemotactic Factors / Q000097:blood* / Q000378:metabolism; D004558:Electric Stimulation; D006133:Growth Substances / Q000097:blood* / Q000378:metabolism; D007030:Hypothalamo-Hypophyseal System / Q000378:metabolism*; D036341:Intercellular Signaling Peptides and Proteins; D008297:Male; D009041:Motion Sickness / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D051381:Rats; D017208:Rats, Wistar; D014667:Vasopressins / Q000097:blood* / Q000378:metabolism; D014722:Vestibule, Labyrinth / Q000502:physiology*
D019743:Chemokines, CXC; D002630:Chemotactic Factors; D006133:Growth Substances; D036341:Intercellular Signaling Peptides and Proteins; D014667:Vasopressins